Microbial biomarker development for detection and prognosis of early-stage non-small cell lung cancer

Abstract excerpt

Non-small cell lung cancer (NSCLC) remains the most common cause for cancer-related mortality despite advances in treatment. Early detection is crucial for improving patient outcomes, yet current diagnostic and prognostic molecular biomarkers lack the sensitivity and specificity necessary to become clinically useful. Recent studies revealed that the lower airway microbiome play a role in NSCLC and that microbial...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Gut microbiota and health
• Share to Lung Cancer Diagnosis and Treatment
• Share to Lung Cancer Treatments and Mutations